Sorafenib Unknown Status Phase 4 Trials for Hepatocellular Cancer Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01849588Sorafenib for Hepatocellular Cancer With Chronic Hepatitis C